128 related articles for article (PubMed ID: 15305206)
1. Theoretical analysis of peptidyl alpha-ketoheterocyclic inhibitors of human neutrophil elastase: Insight into the mechanism of inhibition and the application of QM/MM calculations in structure-based drug design.
Gleeson MP; Hillier IH; Burton NA
Org Biomol Chem; 2004 Aug; 2(16):2275-80. PubMed ID: 15305206
[TBL] [Abstract][Full Text] [Related]
2. 4-Oxo-beta-lactams (azetidine-2,4-diones) are potent and selective inhibitors of human leukocyte elastase.
Mulchande J; Oliveira R; Carrasco M; Gouveia L; Guedes RC; Iley J; Moreira R
J Med Chem; 2010 Jan; 53(1):241-53. PubMed ID: 19904934
[TBL] [Abstract][Full Text] [Related]
3. Synthesis and mechanism of action of novel thiocarbamate inhibitors of human leukocyte elastase.
Li-Pan ZS; Joshi HV; Digenis GA
J Enzyme Inhib; 2000; 15(1):63-77. PubMed ID: 10850955
[TBL] [Abstract][Full Text] [Related]
4. 7-alkylidenecephalosporin esters as inhibitors of human leukocyte elastase.
Buynak JD; Rao AS; Ford GP; Carver C; Adam G; Geng B; Bachmann B; Shobassy S; Lackey S
J Med Chem; 1997 Oct; 40(21):3423-33. PubMed ID: 9341917
[TBL] [Abstract][Full Text] [Related]
5. New peptolides from the cyanobacterium Nostoc insulare as selective and potent inhibitors of human leukocyte elastase.
Mehner C; Müller D; Kehraus S; Hautmann S; Gütschow M; König GM
Chembiochem; 2008 Nov; 9(16):2692-703. PubMed ID: 18924217
[TBL] [Abstract][Full Text] [Related]
6. Binding interaction analysis of the active site and its inhibitors for neuraminidase (N1 subtype) of human influenza virus by the integration of molecular docking, FMO calculation and 3D-QSAR CoMFA modeling.
Zhang Q; Yang J; Liang K; Feng L; Li S; Wan J; Xu X; Yang G; Liu D; Yang S
J Chem Inf Model; 2008 Sep; 48(9):1802-12. PubMed ID: 18707092
[TBL] [Abstract][Full Text] [Related]
7. Structure activity relationship studies of cinnamic acid derivatives as inhibitors of human neutrophil elastase revealed by ligand docking calculations.
Siedle B; Murillo R; Hucke O; Labahn A; Merfort I
Pharmazie; 2003 May; 58(5):337-9. PubMed ID: 12779051
[TBL] [Abstract][Full Text] [Related]
8. Mechanism-based inactivation of human leukocyte elastase via an enzyme-induced sulfonamide fragmentation process.
Wei L; Lai Z; Gan X; Alliston KR; Zhong J; Epp JB; Tu J; Perera AB; Van Stipdonk M; Groutas WC
Arch Biochem Biophys; 2004 Sep; 429(1):60-70. PubMed ID: 15288810
[TBL] [Abstract][Full Text] [Related]
9. Human neutrophil elastase phosphonic inhibitors with improved potency of action.
Winiarski Ł; Oleksyszyn J; Sieńczyk M
J Med Chem; 2012 Jul; 55(14):6541-53. PubMed ID: 22720718
[TBL] [Abstract][Full Text] [Related]
10. Characterizing the dynamics and ligand-specific interactions in the human leukocyte elastase through molecular dynamics simulations.
Estácio SG; Moreira R; Guedes RC
J Chem Inf Model; 2011 Jul; 51(7):1690-702. PubMed ID: 21639142
[TBL] [Abstract][Full Text] [Related]
11. Structure modeling, ligand binding, and binding affinity calculation (LR-MM-PBSA) of human heparanase for inhibition and drug design.
Zhou Z; Bates M; Madura JD
Proteins; 2006 Nov; 65(3):580-92. PubMed ID: 16972282
[TBL] [Abstract][Full Text] [Related]
12. Potent inhibition of human leukocyte elastase by 1,2,5-thiadiazolidin-3-one 1,1 dioxide-based sulfonamide derivatives.
Lai Z; Gan X; Wei L; Alliston KR; Yu H; Li YH; Groutas WC
Arch Biochem Biophys; 2004 Sep; 429(2):191-7. PubMed ID: 15313222
[TBL] [Abstract][Full Text] [Related]
13. Classical polarization in hybrid QM/MM methods.
Illingworth CJ; Gooding SR; Winn PJ; Jones GA; Ferenczy GG; Reynolds CA
J Phys Chem A; 2006 May; 110(20):6487-97. PubMed ID: 16706406
[TBL] [Abstract][Full Text] [Related]
14. 3D-QSAR with the aid of pharmacophore search and docking-based alignments for farnesyltransferase inhibitors.
Vaidya M; Weigt M; Wiese M
Eur J Med Chem; 2009 Oct; 44(10):4070-82. PubMed ID: 19515462
[TBL] [Abstract][Full Text] [Related]
15. Anionic- and lipophilic-mediated surface binding inhibitors of human leukocyte elastase.
Regan J; McGarry D; Bruno J; Green D; Newman J; Hsu CY; Kline J; Barton J; Travis J; Choi YM; Volz F; Pauls H; Harrison R; Zilberstein A; Ben-Sasson SA; Chang M
J Med Chem; 1997 Oct; 40(21):3408-22. PubMed ID: 9341916
[TBL] [Abstract][Full Text] [Related]
16. Azetidine-2,4-diones (4-oxo-beta-lactams) as scaffolds for designing elastase inhibitors.
Mulchande J; Guedes RC; Tsang WY; Page MI; Moreira R; Iley J
J Med Chem; 2008 Mar; 51(6):1783-90. PubMed ID: 18290604
[TBL] [Abstract][Full Text] [Related]
17. Novel thieno[2,3-d][1,3]oxazin-4-ones as inhibitors of human leukocyte elastase.
Gütschow M; Neumann U
J Med Chem; 1998 May; 41(10):1729-40. PubMed ID: 9572899
[TBL] [Abstract][Full Text] [Related]
18. Structure-based design of P3 moieties in the peptide mimetic factor VIIa inhibitor.
Kadono S; Sakamoto A; Kikuchi Y; Oh-eda M; Yabuta N; Yoshihashi K; Kitazawa T; Suzuki T; Koga T; Hattori K; Shiraishi T; Haramura M; Kodama H; Ono Y; Esaki T; Sato H; Watanabe Y; Itoh S; Ohta M; Kozono T
Biochem Biophys Res Commun; 2005 Feb; 327(2):589-96. PubMed ID: 15629154
[TBL] [Abstract][Full Text] [Related]
19. In-depth study of tripeptide-based alpha-ketoheterocycles as inhibitors of thrombin. Effective utilization of the S1' subsite and its implications to structure-based drug design.
Costanzo MJ; Almond HR; Hecker LR; Schott MR; Yabut SC; Zhang HC; Andrade-Gordon P; Corcoran TW; Giardino EC; Kauffman JA; Lewis JM; de Garavilla L; Haertlein BJ; Maryanoff BE
J Med Chem; 2005 Mar; 48(6):1984-2008. PubMed ID: 15771442
[TBL] [Abstract][Full Text] [Related]
20. Structure-based approach to pharmacophore identification, in silico screening, and three-dimensional quantitative structure-activity relationship studies for inhibitors of Trypanosoma cruzi dihydrofolate reductase function.
Schormann N; Senkovich O; Walker K; Wright DL; Anderson AC; Rosowsky A; Ananthan S; Shinkre B; Velu S; Chattopadhyay D
Proteins; 2008 Dec; 73(4):889-901. PubMed ID: 18536013
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
